Earnings
-
Courtesy of Medtronic
Medtronic: Diabetes strategy hasn’t changed amid Abbott partnership
Que Dallara, president of Medtronic’s diabetes unit, said the company still believes in its diabetes technology, but the partnership “allows us to tap into the largest CGM install base in the world.”
By Ricky Zipp • Aug. 20, 2024 -
Permission granted by Neuronetics
Neuronetics inks Greenbrook merger to acquire treatment centers
William Blair analysts said the deal changes Neuronetics’ profile “from device-centric to a device-service business operating brick-and-mortar facilities.”
By Nick Paul Taylor • Aug. 15, 2024 -
Courtesy of 3M
Solventum raises earnings forecast after first independent quarter
Four months after separating from 3M, CEO Bryan Hanson told investors on Solventum’s first earnings call that “a lot could have gone wrong, and it didn’t.”
By Elise Reuter • Aug. 9, 2024 -
Courtesy of Orthogrid Systems
Zimmer to buy surgical navigation company Orthogrid
CEO Ivan Tornos said Zimmer hopes to grow its market share in hip procedures with the purchase. He also shared an update on the company’s new shoulder surgical robot.
By Elise Reuter • Aug. 8, 2024 -
Courtesy of Nevro
Nevro considers sale as competition for pain market ramps up
CEO Kevin Thornal told investors Nevro felt “an urgency” to respond to a market that is being reshaped by direct and indirect competition.
By Nick Paul Taylor • Aug. 8, 2024 -
Bruce Bennett via Getty Images
Henry Schein’s slow recovery from cyber incident hits Q2 results
William Blair analysts said the “lingering impacts from the cyberattack are somewhat surprising.”
By Nick Paul Taylor • Aug. 7, 2024 -
libre de droit via Getty Images
Inari promotes Kevin Strange to CFO
Mitch Hill, who has been in the role since 2019, will retire effective Oct. 1.
By Nick Paul Taylor • Aug. 2, 2024 -
Permission granted by iRhythm Technologies
iRhythm names Daniel Wilson CFO after Brice Bobzien steps down
Along with outlining the succession plan, CEO Quentin Blackford updated investors on an earnings call about the company’s response to an FDA warning letter.
By Nick Paul Taylor • Aug. 2, 2024 -
Courtesy of GE Healthcare
GE Healthcare faces pressure in China as hospitals delay orders
Johnson & Johnson’s medtech business and Philips also cited China’s order slowdown for sluggish revenue growth in the second quarter.
By Susan Kelly • Aug. 1, 2024 -
Courtesy of Stryker
Stryker plans ‘very active’ M&A, ortho robot launches in 2H
After another record quarter of orthopedic robot installations, CEO Kevin Lobo hinted at a potential interest in soft tissue robots.
By Elise Reuter • July 31, 2024 -
Patrik Stollarz / Staff via Getty Images
Philips’ orders and sales held back by China’s anti-corruption push
Hospitals in China increased internal approval cycles to comply with anti-corruption measures.
By Nick Paul Taylor • July 29, 2024 -
Permission granted by Dexcom
Dexcom shares plunge on lower sales outlook
“I’m just kind of in shock,” an analyst said on the earnings call, asking for more detail on the forecast cut.
By Elise Reuter • July 26, 2024 -
Courtesy of Edwards Lifesciences
Edwards spends $1.2B on 2 heart device firms, extending deal streak
Alongside the acquisitions, Edwards reported a slowdown in its core TAVR business in the second quarter that sent its shares tumbling.
By Susan Kelly • July 25, 2024 -
Courtesy of Boston Scientific
Boston Scientific tips strong growth for Farapulse after successful launch
Questions on Boston Scientific’s pulsed field ablation system once again dominated the company’s earnings call.
By Ricky Zipp • July 24, 2024 -
Courtesy of Intuitive Surgical
Intuitive’s da Vinci 5 robot launch ‘well ahead’ of Wall Street expectations
Early customer feedback on the new robot suggests features such as improved ergonomics and vision technology are helping drive adoption, executives said.
By Susan Kelly • July 19, 2024 -
Permission granted by Abbott
Abbott previews PFA, over-the-counter CGM markets
Electrophysiology sales held up against rivals’ launches of pulsed field ablation systems. Meanwhile, Abbott is gauging sales of its first OTC CGMs.
By Elise Reuter • July 18, 2024 -
Mario Tama via Getty Images
J&J medtech fails to meet growth expectations
CFO Joe Wolk told investors Wednesday that Johnson & Johnson’s medical device business missed the company’s 5%-7% growth forecast in the second quarter.
By Ricky Zipp • July 17, 2024 -
Courtesy of Dexcom, Nick Jonas Super Bowl kit
Dexcom to lay off 535 employees in California
A company spokesperson said Dexcom is centralizing its U.S. manufacturing operations in Arizona and repurposing its San Diego facility.
By Ricky Zipp • June 27, 2024 -
Courtesy of Intuitive Surgical
New products take center stage in medtech’s latest earnings season
From pulsed field ablation devices to Intuitive's latest da Vinci robot, product launches dominated recent earnings calls.
By Ricky Zipp • May 28, 2024 -
Courtesy of Medtronic
Medtronic touts demand for PFA, adding to hype for the new ablation tech
CEO Geoff Martha told investors there has already been “strong adoption” of PFA devices and the category will be a big part of Medtronic's revenue growth in fiscal year 2025.
By Ricky Zipp • May 23, 2024 -
Courtesy of Medtronic
Medtronic heads into earnings having seen rivals prosper
J.P. Morgan and RBC analysts are expecting updates on several key markets on Medtronic's Q4 call, including surgical robotics and pulsed field ablation.
By Nick Paul Taylor • May 21, 2024 -
Permission granted by Stryker
Surgical robots are ‘gift that will keep on giving,’ ortho firms say
Stryker, Zimmer and Globus reported double-digit sales growth in their robot segments and outlined plans for new products.
By Elise Reuter • May 9, 2024 -
Patrik Stollarz / Staff via Getty Images
Philips agrees to $1.1B settlement of US respiratory recall lawsuits
CEO Roy Jakobs said on a first-quarter earnings call that “for the U.S., this is as final as it can get.”
By Nick Paul Taylor • April 29, 2024 -
Courtesy of Edwards Lifesciences
Edwards gets Q1 boost as Pascal valve repair sales ramp up
New mitral and tricuspid valve treatments are attracting strong demand, but analysts said transcatheter aortic valve replacement sales were shy of expectations.
By Susan Kelly • April 26, 2024 -
Courtesy of Boston Scientific
Boston Scientific gives first look at Farapulse US rollout
CEO Mike Mahoney would not provide specific sales numbers for the device, but hyped the pulsed field ablation system as the “most transformational product” he’s seen in his time with the company.
By Ricky Zipp • April 24, 2024
